NEWS

MicroVention® announces FDA Clearance for thrombectomy device

SOFIA® Catheter; A New Device for the Revascularization of Patients with Acute Ischemic Stroke

Sensome raises €4.6 million to bring the first connected stroke device t...

Paris, France – Sensome, the company pioneering the connected medical device revolution with the world’s smallest sensor to identify biological tissues, announced today the successful completion of a new 4.6 million euro financing round to bring the Clotild™ smart stroke guidewire to market. Kurma Partners led the existing venture capital syndicate (Paris-Saclay Seed Fund, Idinvest) and other historical investors and was joined by venture capital firm BNP Paribas Developpement.

Please visit us at our Stryker booth at LINNC Paris

LINNC Paris 2018

Access the program

A challenging stroke case

MicroVention announces FDA approval for neuro stent device

MicroVention® Announces FDA Approval For Neuro Stent Device

MicroVention, Inc., a U.S.-based subsidiary of Terumo and a global neurovascular company, announced today the FDA Premarket Approval (PMA) for the LVIS® and LVIS® Jr. stents for stent-assisted coil embolization of intracranial aneurysms. The LVIS® and LVIS® Jr. stents are the first and only stents PMA approved for stent-assisted coil embolization and only the second PMA approved device designed for intracranial aneurysm treatment.

Carotid blowout during attempted thrombectomy

Left MCA Sub occlusion

CONNECTA 2018 - Gathering INR experts from Latin America